الصفحة الرئيسية>>Signaling Pathways>> Ubiquitination/ Proteasome>> Autophagy>>Tubastatin A

Tubastatin A

رقم الكتالوجGC10839 Copy One-Click Copy Product Info

Tubastatin A is a potent and selective HDAC6 inhibitor with an IC50 value of 15 nM . Tubastatin A is also a novel GPX4 inhibitor that directly binds to GPX4 and induces ferroptosis in breast cancer cells.

Products are for research use only. Not for human use. We do not sell to patients.

Tubastatin A التركيب الكيميائي

Cas No.: 1252003-15-8

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
38٫00
متوفر
10mg
38٫00
متوفر
50mg
50٫00
متوفر
100mg
88٫00
متوفر
200mg
151٫00
متوفر
2000mg
1854٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com


مراجعات العميل

بناء على آراء العملاء.

Sample solution is provided at 25 µL, 10mM.



Product has been cited by 1 publications

Description of Tubastatin A

Tubastatin A is a potent and selective HDAC6 inhibitor with an IC50 value of 15 nM [1]. Tubastatin A is also a novel GPX4 inhibitor that directly binds to GPX4 and induces ferroptosis in breast cancer cells[2].

Tubastatin A protected against HCA induced neuronal cell death in a dose-dependent manner. Tubastatin A induced the hyperacetylation of α-tubulin at 2.5 μM[1]. Tubastatin A (32.5µM, 30µM) can inhibit cell colony formation and migration ability and promote apoptosis[3]. Tubastatin A can effectively upregulate the levels of SOD1 and HO-1 and reduce the oxidative stress of chondrocytes [4]. Tubastatin A at 10 μM also significantly inhibited cell proliferation in cholangiocarcinoma cells[5].

Tubastatin A (50mg/kg/day) treatment effectively reduces the expression of HDAC6 in the cartilage of osteoarthritis mice and improves osteoarthritis in mice with surgically destroyed medial meniscus (DMM)[4]. Tubastatin A treatment reduced tumor growth and induces ciliogenesis in rat orthotopic model of cholangiocarcinoma at 10 mg/kg[5].

References:
[1] Butler KV, Kalin J, Brochier C, Vistoli G, Langley B, Kozikowski AP: Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J Am Chem Soc 2010, 132(31):10842-10846.
[2] Liu, Shan., Zhang, Hai-Liang., Li, Jing., Ye, Zhi-Peng., Du, Tian. Tubastatin A potently inhibits GPX4 activity to potentiate cancer radiotherapy through boosting ferroptosis. Redox biology, 2023.
[3] Urdiciain A, Erausquin E, Meléndez B, Rey JA, Idoate MA, Castresana JS. Tubastatin A, an inhibitor of HDAC6, enhances temozolomide-induced apoptosis and reverses the malignant phenotype of glioblastoma cells. Int J Oncol. 2019 May;54(5):1797-1808.
[4] Shen Z, Ji K, Cai Z, Huang C, He X, Xu H, Chen G. Inhibition of HDAC6 by Tubastatin A reduces chondrocyte oxidative stress in chondrocytes and ameliorates mouse osteoarthritis by activating autophagy. Aging (Albany NY). 2021 Mar 19;13(7):9820-9837.
[5] Gradilone SA, Radtke BN, Bogert PS, Huang BQ, Gajdos GB, LaRusso NF: HDAC6 inhibition restores ciliary expression and decreases tumor growth. Cancer Res 2013, 73(7):2259-2270.

Protocol of Tubastatin A

Cell experiment [1]:

Cell lines

LN405 and T98G cells

Preparation Method

LN405 and T98G cells were treated with Tubastatin A at concentrations of 32.5 and 30 µM, respectively, and images were taken under a light microscope at 0, 8, 24, 32 and 48 hours after wounding.

Reaction Conditions

32.5 or 30 µM; 0, 8, 24, 32 and 48h

Applications

Tubastatin A can reduce the migration ability of LN405 and T98G cells.

Animal experiment [2]:

Animal models

Mouse osteoarthritis model

Preparation Method

The osteoarthritis mice were randomly divided into two groups and treated with or without tubastatin A (50 mg/kg intraperitoneally daily), and the mice were killed 8 weeks after surgery.

Dosage form

50 mg/kg/day,8 weeks, i.p.

Applications

Tubastatin A significantly inhibited cartilage surface degradation, tissue and synovial tissue thickening, suppressed ROS levels, and increased the concentration of glycosaminoglycans in the joint cavity.

References:
[1]. Urdiciain A, Erausquin E, Meléndez B, et al. Tubastatin A, an inhibitor of HDAC6, enhances temozolomide-induced apoptosis and reverses the malignant phenotype of glioblastoma cells[J]. International journal of oncology, 2019, 54(5): 1797-1808.

[2]. Zheng Y, Chen Y, Lu X, Weng Q, Dai G, Yu Y, Yu K, Gao W. Inhibition of Histone Deacetylase 6 by Tubastatin A Attenuates the Progress of Osteoarthritis via Improving Mitochondrial Function. Am J Pathol. 2020 Dec;190(12):2376-2386.

Chemical Properties of Tubastatin A

Cas No. 1252003-15-8 SDF
Chemical Name N-hydroxy-4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzamide
Canonical SMILES CN(C1)CCC2=C1C3=C(N2CC4=CC=C(C(NO)=O)C=C4)C=CC=C3
Formula C20H21N3O2 M.Wt 335.4
الذوبان ≥ 10.75 mg/mL in DMSO Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of Tubastatin A

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 2.9815 mL 14.9076 mL 29.8151 mL
5 mM 596.3 μL 2.9815 mL 5.963 mL
10 mM 298.2 μL 1.4908 mL 2.9815 mL
  • حاسبة المولارية

  • حاسبة التخفيف

  • Molecular Weight Calculator

كتلة
=
تركيز
x
مقدار
x
ميغاواط *
 
 
 
** عند إعداد حلول المخزون، دائمًا استخدم الوزن الجزيئي الخاص بالدفعة للمنتج على ملصق القارورة MSDS / CoA (متوفر عبر الإنترنت).

احسب

In vivo Formulation Calculator (Clear solution) of Tubastatin A

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % saline
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL saline, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

مراجعات

Review for Tubastatin A

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%